Complex of gadolinium and a chelating ligand derived from a diastereoisomerically enriched PCTA and preparation and purification process
US12064487B2 · kind B2 · utility
0Cited by
4References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 16, 2023 |
| Grant date | Aug 20, 2024 |
| Priority date | — |
| Expiry date | Jan 16, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a complex of formula (II) constituted of at least 90% of a diastereoisomeric excess comprising a mixture of isomers II-RRR and II-SSS of formulae:The present invention also relates to a process for preparing and purifying said complex of formula (II), and also to a composition comprising said complex.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.